|
| Issue Date | Title | Author(s) |
| 15-Aug-2011 | A phase II study of pazopanib in asian patients with recurrent/metastatic nasopharyngeal carcinoma | Lim, W.-T. ; Ng, Q.-S.; Ivy, P.; Leong, S.-S.; Singh, O.; Chowbay, B.; Gao, F.; Thng, C.H.; Goh, B.-C. ; Tan, D.S.-W.; Koh, T.S.; Toh, C.-K.; Tan, E.-H. |
| 2018 | Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing | Nahar, R; Zhai, W; Zhang, T; Takano, A; Khng, A.J; Lee, Y.Y; Liu, X; Lim, C.H; Koh, T.P.T; Aung, Z.W; Lim, T.K.H ; Veeravalli, L; Yuan, J; Teo, A.S.M; Chan, C.X; Poh, H.M; Chua, I.M.L; Liew, A.A; Lau, D.P.X; Kwang, X.L; Toh, C.K; Lim, W.-T ; Lim, B; Tam, W.L ; Tan, E.-H ; Hillmer, A.M; Tan, D.S.W |
| 1-Jun-2011 | Genomic profiles specific to patient ethnicity in lung adenocarcinoma | Broët, P.; Dalmasso, C.; Tan, E.H. ; Alifano, M.; Zhang, S.; Wu, J.; Lee, M.H.; Régnard, J.-F.; Lim, D.; Koong, H.N.; Agasthian, T.; Miller, L.D.; Lim, E.; Camilleri-Broët, S.; Tan, P. |
| 2015 | Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitors | Jain A.; Lim C. ; Gan E.M.; Ng D.Z.; Ng Q.S.; Ang M.K. ; Takano A. ; Chan K.S. ; Tan W.M.; Kanesvaran R. ; Toh C.K. ; Loo C.M. ; Hsu A.A.L. ; Devanand A. ; Lim C.H. ; Koong H.N. ; Koh T. ; Fong K.W. ; Yap S.P.; Kim S.W.; Chowbay B. ; Oon L. ; Lim K.H. ; Lim W.T. ; Tan E.H. ; Tan D.S.W. |
| 20-Sep-2005 | Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety | Wee, J.; Tan, E.H. ; Tai, B.C. ; Wong, H.B.; Leong, S.S.; Tan, T.; Chua, E.T.; Yang, E.; Lee, K.M.; Fong, K.W.; Tan, H.S.K.; Lee, K.S.; Loong, S.; Sethi, V.; Chua, E.J.; Machin, D. |
